What is the average cost per patient for additional therapy or adverse events after CAR-T therapy administration?
A recent study found that providing treatment in what setting may help improve overall survival in adolescent and young adult patients with acute lymphoblastic leukemia?
According to a presentation at the SGO Annual Meeting, which adverse event associated with PARP inhibitor administration should be a top concern for oncologists?
In a study to test the efficacy of the ASCO Patient-Centered Oncology Payment model, hospitalizations during the active treatment period for ovarian cancer were expected to decrease by what percentage?
From 2007 to 2014, funding from the National Cancer Institute for ovarian and uterine cancers fluctuated by what percentage?
The international workshop on CLL updated the prognostic criteria for their consensus guideline to include all of the following EXCEPT mutational status in which gene?
According to a study presented at the SG0 2018 Annual Meeting on Women’s Cancer, how can ovarian cancer health disparities be improved?
A recent study found that patients with non-Hodgkin lymphoma who received CAR-T therapy benefited, with an overall response rate of what percentage after a median of 15.4 months?
Which first-line treatment strategy was shown to be safe and effective in older patients with newly diagnosed Ph-negative ALL?
According to a recent study, which immunotherapy indication does NOT meet the ASCO value framework threshold for durable survival?